Newmont (NYSE: NEM) MD Rodgers sells 2,051 shares, gets 1,361-share award

Rhea-AI Filing Summary

Newmont Corp executive Mark C. Rodgers, MD, Africa-Asia Pacific, reported mixed equity activity. He completed an open-market sale of 2,051 shares of common stock at $131.14 per share on March 2, 2026, under a pre-established Rule 10b5-1 trading plan dated November 24, 2025.

Earlier, on February 27, 2026, he acquired 1,361 shares of common stock through a grant or award at no cost. Following the March 2 sale, Rodgers directly held 27,117 shares of Newmont common stock.

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

X

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Rodgers Mark C

(Last) (First) (Middle)

6900 E. LAYTON AVE.

SUITE 700

(Street)

DENVER CO 80237

(City) (State) (Zip)

2. Issuer Name and Ticker or Trading Symbol
NEWMONT Corp /DE/ [ NEM ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director		10% Owner
X	Officer (give title below)		Other (specify below)
	MD, Africa-Asia Pacific

3. Date of Earliest Transaction (Month/Day/Year)
02/27/2026

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock, $1.60 par value	02/27/2026		A		1,361	A	$0	29,168	D
Common Stock, $1.60 par value	03/02/2026		S		2,051(1)	D	$131.14	27,117	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

1. The sale reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan dated November 24, 2025.

	/s/ Logan H. Hennessey, Attorney-in-fact for Mark C. Rodgers	03/03/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

FAQ

What insider transactions did Mark C. Rodgers report for NEWMONT (NEM)?

Mark C. Rodgers reported two transactions: an open-market sale of 2,051 Newmont common shares on March 2, 2026, and an acquisition of 1,361 shares via grant or award on February 27, 2026. Both positions are held as direct ownership.

At what price did Mark C. Rodgers sell NEWMONT (NEM) shares?

Rodgers sold 2,051 shares of Newmont common stock at $131.14 per share on March 2, 2026. This transaction was classified as an open-market or private sale and reduced his directly held share balance reported after the transaction.

How many NEWMONT (NEM) shares does Mark C. Rodgers hold after these transactions?

After the March 2, 2026 sale, Rodgers directly held 27,117 Newmont common shares. This balance reflects his holdings following the disposition of 2,051 shares and the earlier acquisition of 1,361 shares through a grant or award transaction.

Was Mark C. Rodgers’ NEWMONT (NEM) share sale under a 10b5-1 plan?

Yes. The Form 4 footnote states the sale was effected pursuant to a Rule 10b5-1 trading plan dated November 24, 2025. Such plans pre-schedule trades, helping insiders systematically sell shares under predetermined conditions.

What type of acquisition did Mark C. Rodgers report for NEWMONT (NEM) stock?

Rodgers reported acquiring 1,361 Newmont common shares on February 27, 2026 as a grant, award, or other acquisition. The shares were recorded at a price of $0.00 per share, indicating a compensation-related equity award rather than an open-market purchase.